Y. Lynn Wang

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

Susan Branford, Linda Fletcher, Nicholas C.P. Cross et al. · Blood · 2008 · 389 citations · Full text

Medicine, Biostatistics, Performance Measurement +9

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Amy V. Jones, Andrew Chase, Richard T. Silver et al. · Nature Genetics · 2009 · 384 citations · Full text

Medicine, Genetics, Hematology +13

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

Shuhua Cheng, Jiao Ma, Ailin Guo et al. · Leukemia · 2013 · 184 citations

Life Sciences, Hematology, Oncology +15

Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis

Shuji Ogino, Kaori Shima, Yoshifumi Baba et al. · Gastroenterology · 2008 · 172 citations · Full text

Medicine, Cancer Biology, Oncology +14

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Helen White, Paul Matejtschuk, Peter Rigsby et al. · Blood · 2010 · 158 citations · Full text

Life Sciences, Genetics, Molecular Biology +5